HORIBA Medical has announced that its haemostatic immunoassay, Yumizen G DDi 2, has been independently validated for the rapid quantification of D-dimer.
Scientists from the Haematology Department, University Hospital of Clermont-Ferrand, have successfully evaluated its analytical performance. They demonstrated it to detect venous thromboembolism (VTE) with excellent accuracy, reliability and turnaround time on HORIBA Medical’s Yumizen G800 fully automated haemostasis analyzer.
D-dimer measurement is one of the most commonly requested tests in the haemostasis laboratory and is frequently used to exclude VTE. While a number of different immunoturbidimetric assays for D-dimer are marketed for routine practice, their reliability and analytical performance can vary. The independent study compared the performance of HORIBA Medical’s Yumizen G DDi 2 assay, designed for its Yumizen G haemostasis analyser range, versus other available immunoturbidimetric D-dimer assays.
The evaluation results are now published in Research and Practice in Thrombosis and Haemostasis and will also be presented at the forthcoming ISTH Congress 2022, to be held in London on 9–13 July.